Chen‐Yuan Lin

Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study

Lin Shen, Ken Kato, Sung‐Bae Kim et al. · Journal of Clinical Oncology · 2022 · 306 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study

Jianming Xu, Ken Kato, Eric Raymond et al. · The Lancet Oncology · 2023 · 291 citations

Medicine, Oncology, Pharmacology +12

Utilizing functional lumen imaging probe topography to evaluate esophageal contractility during volumetric distention: a pilot study

Dustin A. Carlson, Zhiyue Lin, Melinda Rogers et al. · Neurogastroenterology & Motility · 2015 · 91 citations · Full text

Medicine, Surgery, Biomedical Imaging +12

EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis

Chi‐Chen Fan, Sheng‐Ta Tsai, Chen‐Yuan Lin et al. · Redox Biology · 2020 · 56 citations · Full text

Medicine, Cancer Biology, Pharmacology +16

A targeted next‐generation sequencing in the molecular risk stratification of adult acute myeloid leukemia: implications for clinical practice

Po‐Han Lin, Huei‐Ying Li, Sheng‐Chih Fan et al. · Cancer Medicine · 2017 · 53 citations · Full text

Life Sciences, Molecular Genetics, Oncology +17